Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

13.00$ -1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Arcturus Therapeutics Holdings Inc (ARCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 224 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARCT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	56	52	46	42	41	52	–	44	37	44	44	71	87	82	72	150	323	476	481	449	435	393	342	337	294	450	471	431	458	429	419	389	371	344	332	309	282	271	245	224
Current Assets	53	51	46	42	40	51	49	42	34	42	37	63	79	74	64	142	314	468	470	438	421	379	327	292	247	403	425	385	393	387	376	347	331	306	279	275	249	241	217	197
Cash	4.4	2.3	4.7	3.6	3.0	25	-49	40	30	37	31	56	74	71	59	136	307	463	467	434	414	370	320	283	238	392	328	323	312	292	288	315	237	237	217	196	180	231	211	191
Cash & Short-Term Investments	51	50	45	41	40	49	49	40	33	37	31	56	74	71	59	136	307	463	467	434	414	370	320	283	238	392	328	323	312	292	288	315	237	237	217	196	180	231	211	191
Receivables	–	0.5	–	–	–	0.5	–	1.4	1.1	4.5	4.5	5.8	2.6	2.2	2.4	2.8	2.4	2.1	2.0	2.2	2.0	3.4	3.7	2.2	2.0	2.8	92	2.8	38	32	27	24	30	4.0	15	17	8.0	5.6	1.3	1.8
Inventory	–	-0.5	–	–	–	1.5	–	–	0.3	0.0	0.8	1.7	–	–	–	–	0.0	–	0.0	0.0	–	0.0	0.0	–	–	–	–	55	35	0.0	55	0.0	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	1.3	0.2	0.2	0.2	1.0	–	1.9	2.1	2.0	7.7	7.5	7.4	7.5	8.1	7.8	3.5	3.4	3.4	9.7	4.8	11	7.5	9.0	11	–	13	43	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	3.3	4.3	2.2	1.7	2.3	18	–	27	23	31	38	49	51	56	55	57	61	80	129	143	175	165	157	166	148	180	142	145	178	151	155	130	109	103	98	78	58	57	54	53
Current Liabilities	3.3	4.3	2.2	1.7	2.3	11	–	18	14	13	15	16	22	21	22	23	28	50	53	71	118	100	107	93	76	127	90	90	88	82	115	92	69	65	49	47	32	36	34	34
Short-Term Debt	–	-4.3	0.1	–	–	–	–	11	–	–	0.8	0.8	0.8	0.8	1.5	1.3	1.2	2.9	4.6	6.4	20	24	26	30	31	65	4.0	4.1	4.2	4.3	4.3	3.9	3.4	3.6	3.7	4.0	4.1	4.2	4.3	4.0
Accounts Payable	0.2	3.4	0.5	0.0	0.0	1.8	–	2.8	2.9	2.4	4.1	3.2	4.0	5.8	3.8	4.4	6.5	11	5.6	10	8.3	10	10	5.8	18	7.4	19	14	18	5.3	9.1	14	10	7.2	6.2	11	5.5	4.2	4.1	4.4
Long-Term Debt	–	–	–	–	–	–	–	–	–	9.9	9.9	10.0	10	15	15	15	15	14	58	56	42	41	39	36	32	–	–	–	20	–	–	–	–	–	15	–	–	–	–	–
Shareholders' Equity	53	47	44	41	38	34	34	18	14	14	6.4	22	36	26	17	93	262	397	353	306	259	228	185	171	146	270	329	285	280	279	264	259	262	241	234	231	225	214	191	172
Retained Earnings	-90	-96	-99	-103	-105	-23	–	-40	-44	-45	-53	-53	-61	-72	-81	-92	-113	-144	-200	-255	-309	-347	-399	-420	-455	-338	-287	-340	-356	-368	-395	-412	-419	-449	-463	-472	-486	-515	-542	-565
Shares Outstanding	3.9	3.9	3.9	3.5	3.5	10	10	10	10	10	10	10	13	15	15	19	23	26	26	26	26	26	26	26	26	27	27	27	27	27	27	27	27	27	27	27	27	27	28	28

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings